Saturday - May 30, 2026

Category Archives: Science

Hot Flashes Pipeline Drugs Report 2025: Comprehensive Insights into Emerging Therapies, Clinical Developments, and Future Market Opportunities | DelveInsight

DelveInsight’s “Hot Flashes Pipeline Insight 2025” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Hot Flashes pipeline landscape. It covers the Hot Flashes pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Chronic Kidney Disease Pipeline Drugs Report 2025 by DelveInsight: Emerging Therapies, Key Clinical Trials, and Future Outlook Driving Treatment Advancements

DelveInsight’s, “Chronic Kidney Disease Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Chronic Kidney Disease pipeline landscape. It covers the Chronic Kidney Disease pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Cell and Gene Therapy in Parkinson’s Disease Pipeline Drugs Report 2025: Emerging Innovations, Clinical Advancements, and Future Outlook by DelveInsight

DelveInsight’s “Cell and Gene Therapy in Parkinson’s Disease Pipeline Insight 2025” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Cell and Gene Therapy in Parkinson’s Disease pipeline landscape. It covers the Cell and Gene Therapy … Continue reading →

Codex Labs to Exhibit Launch of New L-Histidine Supplements at the American Academy of Pediatrics National Conference

Denver, CO. – September 25th, 2025 – Codex Labs, a biotech skincare company specializing in microbiome-friendly solutions for chronic skincare conditions, is honored to be exhibiting its new eczema supplements for kids at the American Academy of Pediatrics (AAP) National … Continue reading →

Opioid Use Disorder Pipeline Drugs Report 2025: Comprehensive Insights into Emerging Therapies, Clinical Trials, and Market Opportunities Shaping SMA Treatment Landscape

DelveInsight’s “Opioid Use Disorder Pipeline Insight 2025” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in the Opioid Use Disorder pipeline landscape. It covers the Opioid Use Disorder pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Renal Cell Carcinoma Pipeline Outlook Report 2025: Detailed Analysis of Innovative Therapeutics, Ongoing Trials, Regulatory Progress, and Strategic Industry Insights

DelveInsight’s “Renal Cell Carcinoma Pipeline Insight 2025” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in the Renal Cell Carcinoma pipeline landscape. It covers the Renal Cell Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Myocardial Infarction Pipeline Drugs Report 2025: Evaluating Cutting-Edge Therapies, Clinical Trial Milestones, Key Companies, and Emerging SMA Treatment Options

DelveInsight’s, “Myocardial Infarction Pipeline Insight, 2025” report provides comprehensive insights about 30+ companies and 40+ pipeline drugs in Myocardial Infarction pipeline landscape. It covers the Myocardial Infarction pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Obesity Pipeline Drugs Report 2025 by DelveInsight: Analysis of Current and Future Therapeutics, Trial Updates, and Emerging Opportunities in SMA

DelveInsight’s “Obesity Pipeline Insight 2025” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Othe besity pipeline landscape. It covers the Obesity pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Obesity therapeutics … Continue reading →

Type 2 Diabetes Pipeline 2025 Report: Strategic Overview of Ongoing Research, Drug Candidates, Market Trends, and Upcoming Approvals

DelveInsight’s “Type 2 Diabetes Pipeline Insight, 2025” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Type 2 Diabetes pipeline landscape. It covers the Type 2 Diabetes pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →